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Close contact between T lymphocytes and keratinocytes is an 
important feature of many inflammatory skin diseases. III 
vitro studies showed that stimulation of keratinocytes with 
interferon-y or tumor necrosis factor-a and of T cells with 
phorbol esters results in a leukocyte function-associated anti-
gen {LFA)-ljintercellular adhesion molecule (ICAM)-l -
mediated adhesion. The present study was performed to in-
vestigate the role of the CD44 molecule in keratinocytej 
T -cell binding. The CD44 class of lymphocyte adhesion 
receptors is involved in lymphocyte binding to high endothe-
lial venules and to extracellular matrix compounds and is 
therefore important in lymphocyte recirculation and hom-
A characteristic finding in a large number of benign (e.g., psoriasis) and malignant (e.g., mycosis fun-.goides) skin diseases is the close contact between kera-tinocytes and T lymphocytes in the epidermis. The keratinocytes in the neighborhood of a heavy mononu-
clear inflammatory infiltrate express the intercellular adhesion mol-
ecule (ICAM)-1, a ligand for leukocyte function-associated antigen 
(LFA)-1 on T lymphocytes and monocytes [1- 3]. In vitro experi-
ments showed that the adhesion molecules ICAM-1 and LFA-1 are 
responsible for the binding of T lymphocytes to keratinocytes [4-
6]. The LFA-1 molecule on resting T lymphocytes is present in an 
inactive form and can be activated by phorbol esters and monoclonal 
antibodies directed against the cell-surface molecules CD2 and 
CD3, which leads to enhanced ligand binding [7 -12]. Recent ex-
periments demonstrated that triggering of the CD44 molecule on T 
lymphocytes by anti-CD44 monoclonal antibodies induced homo-
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Abbreviations: 
EDTA: ethylenediaminetetraacetic acid 
HBSS: Hank's balanced salt solution 
HLA: human leukocyte antigen 
!CAM-I: intercellular adhesion molecule 1 
Ig: immunoglobulin 
LFA-l: leukocyte function associated antigen 1 
PBML: peripheral blood mononuclear leukocytes 
PMA: phorbol myristate acetate 
ing. Moreover, CD44 can act as a co-stimulating signal in 
T -cell activation and promotes homotypic adhesion of ill vitro 
cultured CD3-stimulated T cells. Using a cell adhesion assay 
a sixfold increase in T-celljkeratinocyte adhesion was found 
after pre-incubating the T cells with anti-CD44. This in-
creased adhesion was found to require an intact cytoskeleton, 
to be energy and magnesium dependent, and could be com-
pletely inhibited by anti-LFA-l and anti-ICAM-l. Pre-
treatment ofT cells with hyaluronic acid, a ligand for CD44 
and an extracellular matrix compound in the dermis and 
epidermis, did not affect T -celljkeratinocyte adhesion. ] IIl-
vest DermatoI100:424-428, 1993 
typic adhesion mediated by LFA-1 [13,14]. The CD44 molecule isa 
broadly distributed cell-surface protein [15] thought to be involved 
in several steps of normal immune cell function, including T-cell 
activation [16,17] and lymphocyte adhesion to high endothelial 
venules [18,19] and the extracellular matrix [20]. CD44 is thought 
to be the principal cell surface receptor for hyaluronic acid [21,22] , 
which has been shown to be the predominantly synthesized extra-
cellular matrix component in the dermis and epidermis [23,24]. 
These findings prompted us to study the influence of CD44 trig-
gering by anti-CD44 monoclonal antibody and by hyaluronic acid 
on T -lymphocyte/keratinocyte adhesion. 
MATERIALS AND METHODS 
T -Lymphocytes and Keratinocytes 
T-Lymphocytes: Human peripheral blood mononuclear leukocytes 
(PBML) from healthy volunteers were obtained by centrifugation 
of defibrinized venous blood over a Ficoll-Paque density gradient 
(Pharmacia, Upsala, Sweden). The interface cells were collected 
and washed with RPMI-1640 (ICN Biomedicals, Zoetermeer, The 
Netherlands), supplemented with 5% heat-inactivated fetal calf 
serum (Gibco, Breda, The Netherlands). The PBML were depleted 
of B lymphocytes and monocytes by filtration over nylon wool 
(99% T lymphocytes) and resuspended in RPMI-1640 with 5% 
fetal calf serum at a concentration of 2 X 106 cells/ml. 
KeratirlOcytes: The simian virus 40-transformed human keratino-
cyte cell line SVK14 was cultured in Dulbecco's modified Eagle's 
medium and Ham's F12 (3: I), supplemented with 10% fetal calf 
serum, 0.4 J.Lg/ml hydrocortisone (Sigma Chemical Co., St. Louis, 
MO), 2 mM L-glutamine, 100 U/ml penicillin and 100 J.Lg/m1 
streptomycin (Flow). The keratinocytes were induced to express 
ICAM-1 by pre-treatment with interferon (IFN)-y (300 U/m1; 
Janssen Biochemica, Belgium) during 48 h. 
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Monoclonal Antibodies a~d Chemicals. The following mono-
lonal antibodies were used m a concentration of approximately 20 ~g/ml: NKI-Pl [CD44, immunoglobulin (Ig) Gl, provided by CG 
Figdor, Amsterdam, The Netherlands] [15]; RRI/l (CD54, antl-
ICAM-l, IgGl , provided by TA Springer, Boston, M~); IB4 
(CD18, anti-LFA-lP, IgG2A)[25]; TB133 (CDlla, antl-LFA-
la, IgG 1, provided by F. Miedema, Amsterdam, The Netherlan?s); 
AICD58 (CD58, anti-LFA-3, IgG2A; Immun?tech, Marseille, 
France); OKT11 (CD2, IgG2A; Ortho Diagnostics, Rantan, N]); 
RIV-6 (CD4, IgG2A; Sanbio, Udem, The Netherl.ands); OKT8 
(CD8, IgG2; Ortho Diagnostics); CLB-H2.5.10 (anti-human leu-
kocyte antigen (HLA)-DR, IgG 1; Central Laboratory of the Neth -
erlands Red Cross Blood Transfusion Service, .Amste.rdam, The 
Netherlands); BBA5 (anti-VCAM-1, IgG1; Bntlsh B~o-technol­
ogy Ltd., Abingdon, UK); and HP2/1 [CDw49d, anti-very lare 
antigen (VLA-4), IgG1, Immunotech]. The reagents .used. were 
horbol-12-myristate 13-acetate (PMA) (5 ng/ml, 30 rom, Sigma); 
hyaluronic acid (Sigma); sodium azide alone (0.1 %; Sigma), an 111-
hibitor of oxidative phosphorylation, or together with deoxyglu-
cose (50 nM; Sigma), which inhibits ~he glycolysIs; H7 (1- 5 ISO-
quinolinyl su l f~ny l -2-methy l plperazlde, 20 ,uM; Sl~ma), whlcl~ 
revents activatIOn of protell1 kll1ase A and protem kll1ase .C [26], 
\v7 [N-( 6-aminohexyl)-5-chloro-l-naphtalene sulfonal~1Ide.' 20 
JiM; Sigma], an inhibitor of calmoduline-dependent protem kmase 
activation [27], and cytochalasin B (20,uM; Sigma), which II1hlbltS 
microfilament formation [28]. 
Binding Assay 
Enzyme-Lillked 111I1II1IIlOSorbellt Cell Adhesion Assay: As previously 
described, mono layers of keratinocytes were grown untl.1 confluent 
in 96-well microtiter plates in the presence or absence of II1terferon-
. T lymphocytes were co-incubated with the washed keratll10cytes ~or 60 min at 37"C. Afterward, the non-adherent T cells were re-
moved from the wells by washing. The adherent T ~ells were fixed 
and incubated for 30 min with a monoclonal antibody dlrec~ed 
against the leuko~yte comm?n antigen,. which was labeled ~Ith 
horseradish peroxidase; 10 mm after addll1g the substrate solutIOn, 
the reaction was stopped, and the extinction values were measured 
at 492 nm in a Titertek Multiscan [29] . . 
Prior to the adhesion assay, the T lymphocytes wer~ pre-mc~­
bated with anti-CD44 monoclonal antibody or PMA dunng 30 mm 
at room temperature. To study the mechanism of CD44-m~uced 
T -cell/keratinocyt~ adhesi.on, the T -lymphocytes were pre-I~cu­
bated with the vanous II1lllbltors of cell metabolism. for 15 mll1 at 
37°C before adding the anti-CD44 monoclonal antibody. 
The requirement for magnesium was studied by waslllng the T 
cells and keratinocytes in Hanks' balanced salt solutIOn ~H~SS) 
without magnesium. It was not possible t? use ethylenedl~mll1e­
tetraacetic acid (EDT A) to deplete the medium entirely o~ bivalent 
cations. EDTA disrupted the keratinocyte monolayer, which made 
it impossible to perform the adhesion assay. The T cells were resus-
pended in HBSS supplemented with 2 mg/ml D-glucose and.1 % 
bovine serum albumin and no magnesium, 1 or 5 mM magnesIUm 
(Gibco) was added to the medium. . . 
The role of adhesion molecules was detenmned by pre-lI1.cubat-
ing the anti-CD.44 pre-treated T cells or t~e keratinocytes With the 
monoclonal antibody dunng 30 mll1 at 37 C. The effect on T-~ell/ 
keratinocyte adhesion of hyaluronic acid was investigated by either 
addition of hyaluronic acid to the T-cell suspensIOn (1,10,100 aond 
1000,ug/ml) and incubation during 0.5,1,24,48, and 72 I: at 37 C 
or incubating the T cells in a hyaluronic acid-coated plastiC well (5 
mg/ml) during 1, 24, and 48 h at 37 ° C. After washll~g , the T cells 
were co-incubated with the keratinocytes in the adheSIOn assay, and 
the amount of adhesion was measured. 
RESULTS 
Anti-CD44 Pre-Treatment Induces T-Cell Adhesion to 
ICAM-I-Positive Keratinocytes Unstimulated T cells 
showed minimal adhesion to ICAM-l - positive keratinocytes. 
After a 30-min pre-incubation with the anti-CD44 monoclonal 
CD44-INDUCED T-CELL/KERATINOCYTE ADHESION 425 
0.30 
0.25 
E 0.20 s::: 
N 
01 
"" s::: 
0.15 
~ 
0 
s::: 0.10 ~ 
w 
0.05 
0.00 
CD44 PMA 
Figure 1. Anti-C044 pre-treatment induces T-cell adhesion to ICAM-
l-positive keratinocytes. The amount of binding T cells is represented by 
the extinction value measured at 492 nm; - non-activated T cells; (C044) 
T cells pre-treated with anti-C044; (PMA) T cells pre-treated with PMA: 
bars represent the mean of four experiments (n = 32) ± SO. 
antibody NKI-Pl, otherwise unstimulated T cells showed a sixfold 
increase in adherence to ICAM-l - positive keratinocytes. As a con-
trol, the adhesion of PMA-activated T cells was measured, which 
showed an eightfold increase (Fig 1). 
CD44-Induced T-Cell/Keratinocyte Adhesion is Energy De-
pendent and Requires an Intact Cytoskeleton The metabolic 
requirements of CD44-induced T-cell/keratinocyte adhesion was 
investigated by adding the following chemicals to the T-cell suspen-
sion 15 min before the anti - CD44 monoclonal antibody was 
added. Addition ofH7, which interferes with protein kinase C and 
A, reduced the T -cell/keratinocyte adhesion to 30% of the maximal 
adhesion, whereas W7, a calmoduline-dependent protein kinase 
inhibitor, inhibited the CD44-induced binding completely. Addi-
tion of cytochalasin B, which prevents formation of microfil a-
ments, also led to a complete inhibition of the CD44-induced bind-
ing. The addition of sodium azide alone, an inhibitor of oxidative 
phosphorylation, resulted in a 60% reduction, but the addition of 
sodium azide plus deoxyglucose, an inhibitor of glycolysis, pre-
vented the T-cell/keratinocyte binding completely (Fig 2). 
CD44-Induced T-Cell/Keratinocyte Adhesion Is Magne-
sium Dependent Although in the assay conditions that were 
applied, the bivalent cations were not totally removed, a decrease 
was still seen in the T -cell/keratinocyte adhesion. This decrease was 
partly abolished by adding 1 mM magnesium to the medium, and 
the addition of 5 mM magnesium restored the binding completely. 
This effect was not found by adding 1 or 5 mM calcium (data not 
shown). 
CD44-Induced T-Cell/Keratinocyte Adhesion Is LFA-l/ 
ICAM-l Dependent Potentially inhibitory or controlmonoclo-
nal antibodies were added to the CD44 - pre-treated T cells or to the 
keratinocyte monolayer 30 min prior to the adhesion assay. The 
monoclonal antibodies directed against the LFA-la and LFA-lP 
chain on the T cel ls and the monoclonal antibody directed against 
ICAM-l on the keratinocytes blocked the CD44-induced T-cell! 
keratinocyte adhesion almost completely (Fig 3A, B). The monocl.o-
nal antibodies against CD2, CD4, CD8, VLA-4, CD58, major 11Is-
tocompatibility complex (MHC) I, HLA-DR, and VCAM-l had no 
major influence on T -cell/keratinocyte adhesion. 
T-Cell Pre-Treatment with Hyaluronic Acid Did Not Induce 
T-Cell/Keratinocyte Adhesion CD44 is th.e pnnclpal ligand 
for the extracellular matrix component hyalurol1lc aCid. To IIlvestl-
426 BRUYNZEEL ET AL 
120 
100 
80 
c: 
.2 
en 
Gl 60 .c 
"C 
c( 
~ 0 
40 
20 
o 
CD44 H7 W7 CYTO AZ AZ+DG 
Figure 2. Metabolic requirement for CD44-induced T -cell/keratinocyte 
adhesion. CD44-induced adhesion is set at 100%. The T cells are pre-in-
cubated with the various inhibitors of cell metabolism; bars represent the 
mean of two experiments (n = 16) ± SD. (Cyto, cytochalasin B; A2, so-
dium azide; DG, deoxyglucose.) 
gate whether hyaluronic acid could also induce T -cell/keratinocyte 
adhesion, aT-cell suspension was pre-incubated with hyaluronic 
acid prior to the adhesion assay. Pre-treatment during 0.5 h (1,10, 
100, and 1000 Jig/ml) and during 1 and 24 h (10 Jlg/ml) did not 
lead to T -cellJkeratinocyte adhesion. Pre-treatment during 48 and 
72 h (10 Jig/ml) did induce T-cell/keratinocyte adhesion, but the 
same induction was found when T cells without hyaluronic acid 
were incubated at 37°C during 48 and 72 h (Fig 4). This adhesion 
was almost completely blocked by anti-LFA-lP (data not shown). 
When a T-cell suspension was incubated (1, 24, and 48 h) in a 
plastic well coated with hyaluronic acid (5 mg/ml), no adhesion of 
the T cells to the plastic well was found, neither with unactivated 
nor with PMA-activated T cells. The unactivate.d T cells were col-
lected and co-incubated with ICAM-l-positive keratinocytes in 
the adhesion assay, but, again, no increased adhesion was measured. 
DISCUSSION 
The CD44 class oflymphocyte adhesion receptors is thought to be 
involved in a wide range of immunologic functions. CD44 can act 
as a co-stimulating signal in CD2 or CD3-mediated T-cell activa-
tion and cell proliferation [11,12,17] and is a promotor of homo-
typic T-cell adhesion [13,14]. CD44 is involved in T-cell adhesion 
to erythrocytes [17,30]' to extracellular matrix compounds [31], and 
to high endothelial venules [18,19]. The anti-CD44 monoclonal 
antibody Hermes-3 inhibits lymphocyte binding to mucosal high 
endothelial venules [32]. Lymphocyte binding to peripheral 
lymph-node high endothelial venules was blocked up to 40% with 
the anti-CD44 monoclonal antibody NKI-PP [15] . The monoclo-
nal antibodies Hermes-l and Hermes-3, both recognizing the 
CD44 class of lymphocyte homing receptors, were bound by infil-
trating lymphocytes in skin biopsy material of de(matitis herpeti-
formis, psoriasis, mycosis fungo ides, lymphocytosis cutis, atopic 
dermatitis, and allergic contact dermatitis, suggesting that CD44 is 
also involved in lymphocyte homing to inflamed skin [33] . The 
distribution pattern of Hermes-l is similar to that of the monoclonal 
antibody NKI-Pl used in the present study [15]. A monoclonal 
antibody against CD44 expressed on cytotoxic T lymphocytes was 
'Dinther-janssen ACHM van, Kraal G, Scheper Rj, Willernze R, Meijer 
CJLM: Adhesion molecules involved in the extravasation of lymphocytes 
in lymphoid organs and chronically inflamed tissues. In: Lamb~rt CW, 
van Vloten WA. Basic mechanisms of physiologic and aberrant lympho-
proliferation in the skin. Plenum Press, New York (in press). 
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Figure 3. Monoclonal antibody inhibition studies of CD44-induced T-
cell/keratinocyte adhesion. CD44-induced adhesion is set at 100%. (AJ 
CD44 pre-treated T cells are pre-incubated 30 min prior to the adhesion 
assay with monoclonal antibodies directed against CD2, CD4, CD8, 
CD18a and P chain, and VLA4. (B) The ICAM-l-positive keratinocytes 
are pre-incubated 30 min prior to the co-incubation with the CD44 pre-
treated T cells, with monoclonal antibodies directed against CD58, HLA-
DR, CD54, and VCAM-l; bars represent the results of one experiment 
(n = 8) ± SD. 
also found to be capable of triggering the lytic activity of cytotoxic 
T lymphocytes and redirecting cytotoxic T -lymphocyte - mediated 
lysis, which mechanism may account for the non-specific tissue 
damage seen at sites of cytotoxic T -lymphocyte - mediated inflam-
mation [34]. In this study, it was demonstrated that triggering of the 
CD44 molecule also induces otherwise unstimulated, freshly iso-
lated peripheral blood T cells to adhere to ICAM-l- positive kerati-
nocytes. In recent literature, the influence of anti-CD44 on homo-
typic cell aggregation was described; however, the T-cell lines or 
myelomonocytic cell lines used had to be stimulated for 24 h or for 
2 h in combination with anti-CD3 or after stimulation of the cells 
with aT-cell growth factor. Freshly isolated T cells had to be 
incubated with anti-CD44 for 4-18 h [13,14]. In our studies, the 
maximum effect on T-cell/keratinocyte adhesion was found after a 
30-min incubation of the T cells with anti-CD44. This CD44-in-
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Figure 4. Influence of hyaluronic acid on T -celljkeratinocyte adhesion. 
T-celljkeratinocyte adhesion is represented as the extinction value mea-
sured at 492 nm. T cells are pre-incubated with hyaluronic acid (10 J.lgj 
mI) (stippled bars) or without (open bars) during 0.5,1, 24, 48, and 72 h prior 
to the adhesion assay at 37°C. The results of oneexperiment(n = 8) ± SD 
are shown. 
duced adhesion was found to depend on intracellular protein kinase 
activiry because the adhesion was largely prevented by adding !17, 
an inhibitor of protein kinase A and C. The inhibition of the bInd-
ing by adding cytochalasin B, sodium azide, or sodium azi~e plus 
deoxyglucose shows that the CD44-induced T-cell/ker~tlnocyte 
adhesion requires an intact cytoskeleton and cell metabolism. The 
CD44-induced T-cell/keratinocyte adhesion is mediated by LFA-1 
and ICAM-1 because it can be inhibited by monoclonal antibodies 
directed against LFA-1 and ICAM-1 but not by the other mon.oclo-
nal antibodies used. Recent studies have shown that CD44 IS the 
principal ligand for hyaluronic acid, which is the pred?minantix 
synthesized extracellular matrix component i~ th.e dermiS and epI-
dermis. One may therefore speculate that binding of T cells to 
hyaluronic acid in vivo has the same effect o~ these ~ cells .throug~ 
triggering of the CD44 molecule as pre-incubation :Vlth a~tI­
CD44 in vitro. For that reason, we investigated whether incubation 
ofT cells with hyaluronic acid also resulted in an increased T-cell/ 
keratinocyte binding; however, no difference in T-~ell/kera.tino­
cyte adhesion was fO'.lnd ~etween T cells in suspe~lSlon pre-In~u­
bated with hyalurol1lc aCid and T cells not pre-Incubated with 
hyaluronic acid. The LFA-1-mediated increased adhesion found 
after 48 and 72 h of incubation of T cells with or without hyal-
uronic acid can be explained by activation of the LFA-1 molecule by 
serum components and T-cell products in the incubation medium. 
Miyake et al described the binding of B-lineage hybridom~ ~ells to 
hyaluronic acid-coated plastic wells, which could be inhibited .by 
monoclonal antibodies to CD44 [22] . In our experiments With 
freshly isolated unstimulated human T lymphocytes, no adhesion of 
the T cells to the hyaluronic acid-coated plastic well was found 
after 1, 24, or 48 h of incubation. After incubation in the hyaluronic 
acid-coated wells, the T cells did not adhere to the ICAM-1-
positive keratinocytes either, leading to the conclusion that no "ac-
tively binding LFA-1" was formed on the T cells. This is n?t sur-
prising because no interaction of the T cells with hyalurol1lc aCid 
had taken place. Also, PMA-activated T cells did not adhere to the 
hyaluronic acid -coated rlastic wells. The most likely explanation 
of the different results o. Miyake et aI's and our experiments is the 
difference in the activation state of the cell rypes used: B-lineage 
hybridoma cells versus freshly isolated, peripheral blood T cells. 
Murakami et al found that the binding of interleukin 5 - activated B 
cells to hyaluronic acid - coated surface was greater than the binding 
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of unactivated B cells and could be inhibited by anti-CD44 [35]. 
Lesley et al also found that certain CD44-positive T - and B-ceillines 
adhered to hyaluronic acid-coated dishes; however, normal hema-
topoietic cells, such as bone-marrow myeloid cells and splenic lym-
phocytes, and other CD44-positive cells (two thymoma cell lines) 
showed no detectable hyaluronic acid binding activiry [36]. Re-
cently, Lesley et al showed that some CD44-positive cell lines, 
which did not adhere to hyaluronic acid, could be induced to hyal-
uronic acid binding by incubating the cells with the CD44 monoclo-
nal antibody IRAWB 14 [37]; however, adding the anti-CD44 
monoclonal antibody NKI-P1 to freshly isolated T cells did not lead 
·to adhesion to hyaluronic acid either (1. Bruynzeel et ai, unpublished 
observations, September, 1992). Probably, the CD44 molecule (i.e., 
the hyaluronic acid receptor) on T cells exists in an inactive state 
[36], and activation of the receptor is needed (e.g., by adhering to 
endothelial cells before migrating through the vessel wall into the 
dermis, where interaction with hyaluronic acid can take place). 
Altho~gh t:urther studies are necessary to clarify the process of T-
cell mlg~atlo": through the dermis to the epidermis, the effect of 
CD44 tnggenng on T-cell adhesion to keratinocytes through the 
LFA-1/ICAM-1 pathway seems to be an important step. 
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ANNOUNCEMENT 
The annual meeting of the Society for Pediatric Dermatology will be held July 28-31, 1993 at 
Snowmass, Colorado. The meeting will immediately follow the 42nd annual Symposium on 
the Biology of Skin. Those wishing further information please write to: 
SPD-Snowmass 
Department of Dermatology B-153 
University of Colorado School of Medicine 
4200 East Ninth Avenue ' 
Denver, Colorado 80262 
